Suppression of protein degradation in progressive cardiac hypertrophy of chronic aortic regurgitation.
BACKGROUND
The heart adapts to the volume overload of aortic regurgitation with dilation and hypertrophy. The development of left ventricular hypertrophy at the protein level is a dynamic process resulting from an imbalance between cardiac protein synthesis and degradation. The objective of the present study was to determine in vivo the relative contributions of cardiac protein synthesis and degradation to the progressive hypertrophy that occurs in response to chronic aortic regurgitation and to compare these with responses earlier in the course of this stress.


RESULTS
Continuous intravenous infusions of [3H]-leucine were administered 3 days and 1 month after surgical induction of aortic regurgitation and sham operation in rabbits. Total cardiac protein and myosin heavy chain fractional synthesis rates were obtained by analysis of plasma and protein hydrolysate data using [14C]-dansyl chloride assays. Left ventricular growth rates were determined from serial echocardiographic and postmortem left ventricular weight and protein concentration measurements; protein degradation rates were determined by subtraction of growth rates from synthesis rates.


CONCLUSIONS
In comparison with sham-operated control rabbits, protein fractional synthesis rates were increased at 3 days but not at 1 month after induction of aortic regurgitation Progressive cardiac hypertrophy occurring at 1 month was caused by a decrease in protein fractional degradation rates. An increase in protein synthesis contributes only to the early phase of hypertrophy caused by acute aortic regurgitation, whereas progressive eccentric hypertrophy in chronic volume overload is due to suppression of protein degradation.
Magid
N M
NM
Department of Medicine, Cornell University Medical College, New York Hospital-Cornell Medical Center, NY 10021.
Borer
J S
JS
Young
M S
MS
Wallerson
D C
DC
DeMonteiro
C
C
D000818:Animals; D001022:Aortic Valve Insufficiency / Q000150:complications / Q000378:metabolism*; D002908:Chronic Disease; D004452:Echocardiography; D017379:Hypertrophy, Left Ventricular / Q000000981:diagnostic imaging / Q000209:etiology / Q000378:metabolism*; D007930:Leucine / Q000378:metabolism; D009124:Muscle Proteins / Q000378:metabolism*; D009206:Myocardium / Q000378:metabolism*; D009218:Myosins / Q000378:metabolism*; D011817:Rabbits; D013997:Time Factors; D014316:Tritium
D009124:Muscle Proteins; D014316:Tritium; D009218:Myosins; D007930:Leucine